|
2025
|
Invention
|
Combination therapy for treating glioblastomas. LL-[131LL-[131I]iodo-phenylalanine suitable for i... |
|
2024
|
Invention
|
Novel radiolabelled antibodies. The invention relates to radiolabelled girentuximab antibodies an... |
|
|
Invention
|
Humanised antibodies and uses thereof. The invention relates to humanised antibodies for binding ... |
|
|
Invention
|
Antibodies against caix with reduced affinity for the neonatal fc receptor.
The invention relate... |
|
|
Invention
|
Methods of treating cancers expressing pdgfralpha. The invention relates to compositions comprisi... |
|
|
Invention
|
Multifunctional antibodies. The invention relates to molecules comprising a tumour antigen bindin... |
|
2023
|
Invention
|
Novel therapeutic targets. The invention relates to proteins and compositions for the treatment o... |
|
|
Invention
|
Imaging reagents and methods. A method for in vivo imaging or detection of a cancer in a subject ... |
|
|
Invention
|
Radiolabelled compounds. Processes for the synthesis of [8944 from [8944]4-salt are provided. The... |
|
|
Invention
|
Combination therapy. The invention relates to methods and compositions for use in combination rad... |
|
|
Invention
|
Reagents and methods for imaging cancers expressing pdgfralpha. The invention relates to reagents... |
|
2022
|
Invention
|
Preparatory process.
The disclosure provides a process of preparing an iron complexed conjugate ... |
|
|
Invention
|
Aggregate separation method.
The disclosure provides methods of removing aggregate from a compos... |
|
|
Invention
|
Combination radiotherapy.
The present invention relates to methods for treating diseases and con... |
|
|
Invention
|
Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereof.
The... |
|
2020
|
Invention
|
Antibodies for binding psma with reduced affinity for the neonatal fc receptor.
The invention re... |
